Class / Patent application number | Description | Number of patent applications / Date published |
514160000 | With additional ortho-hydroxybenzoic acid compound | 15 |
20100210604 | ZWITTERION SOLUTION FOR LOW-VOLUME THERAPEUTIC DELIVERY - A formulation is provided that includes a volume of an aqueous multivalent physiological ion solution compatible with cerebrospinal fluid containing at least one divalent cation of magnesium or calcium, and at least one anion of carbonate or phosphate, and having a pH between 6.5 and 8.0. A zwitterionic therapeutic agent other than baclofen is dissolved the solution to achieve higher concentration or ease of solution and/or storage relative to therapeutic saline solutions of the same agent. A process of delivering a zwitterionic therapeutic agent into a subject is provided that includes dissolving a therapeutic amount of the zwitterionic therapeutic agent in a volume of artificial cerebrospinal fluid to form a stable formulation. The solution is then administered to the subject using an intrathecal pump. | 08-19-2010 |
20110201578 | COMPOSITION AND METHODS FOR THE TREATMENT OF PSEUDOFOLLICULITIS BARBAE AND SKIN IRRITATION - The invention comprises a composition for the treatment of pseudofolliculitis barbae and a method of use therefor. Preferred embodiments include compositions containing one or more of active ingredients L-arginine, acetylsalicyclic acid, and salicyclic acid adjusted to a pH in the range of 4.0 to 6.0. Preferred compositions include: a carrier, such as water; a moisturizer, such as propylene glycol, and one or more of the active ingredients. Application of a composition for the treatment of pseudofolliculitis barbae with a pH of about skin does not disrupt normal skin functioning. | 08-18-2011 |
20120322771 | GLYCERYL AND GLYCOL ACID COMPOUNDS - Disclosed is a method for reducing the appearance of a fine line or wrinkle on skin comprising topically applying to said fine line or wrinkle a composition comprising a glyceryl di-salicylate compound having the following structure: | 12-20-2012 |
20130157985 | PAIN RELIEF COMPOSITIONS, MANUFACTURE AND USES - The present invention relates to TRPV1 selective agonist topical compositions including capsaicinoid and analgesic agent compositions and methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions. | 06-20-2013 |
20130261090 | METHOD FOR TREATMENT OF SORES IN THE ORAL CAVITY WITH A COMPOSITION CONTAINING ULTRAVIOLET LIGHT-ABSORBING INGREDIENTS - The invention provides a method for treating ulcerations of the oral cavity, such as canker sores, sores associated with hand, foot, and mouth disease (HFMD), and sores associated with herpangina, with compositions containing ultraviolet light-absorbing ingredients. The ultraviolet light-absorbing ingredients include avobenzone, homosalate, octisalate, octocrylene, and/or oxybenzone. These treatments accelerate the healing process of the ulcerations of the oral cavity. | 10-03-2013 |
20130310349 | GLYCERYL AND GLYCOL ACID COMPOUNDS - Disclosed is a method for moisturizing skin comprising topically applying to skin in need of moisturization a composition comprising a glyceryl di-salicylate compound having the following structure: | 11-21-2013 |
20140018329 | COMPOSITIONS AND METHODS OF USE OF PHORBOL ESTERS IN THE TREATMENT OF NEOPLASMS - Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment of chronic and acute conditions. Such conditions may be caused by disease, be symptoms, treatments, or sequelae of disease. The phorbol esters described are particularly useful in the treatment of neoplastic diseases and/or managing the side effects of chemotherapeutic and radiotherapeutic treatments of neoplastic diseases. | 01-16-2014 |
20140179641 | Collagen Stimulators and Their Use in the Treatment of Skin - Methods for preventing, ameliorating, or reducing dermatological signs of aging are provided which employ cosmetic composition comprising novel active agents that enhance collagen production in the skin. | 06-26-2014 |
20140274973 | AROMATIC CARBOXYLIC ACIDS IN COMBINATION WITH AROMATIC HYDROXYAMIDES FOR INACTIVATING NON-ENVELOPED VIRUSES - The present invention is directed to antiviral compositions that provide efficacy against non-envelope viruses such as noroviruses. The antiviral compositions comprise an alcohol and a synergistic combination of an aromatic carboxylic acid and an aromatic hydroxyamide. The composition may be used as a topical on human skin, as a hand sanitizer or as a hard surface cleaning composition. | 09-18-2014 |
20140323444 | ANTI-INFLAMMATORY AND ANTIDIABETIC AGENTS - The present invention relates to compounds, | 10-30-2014 |
20150045331 | Collagen Stimulators and Their Use in the Treatment of Skin - Methods for preventing, ameliorating, or reducing dermatological signs of aging are provided which employ cosmetic composition comprising novel active agents that enhance collagen production in the skin. | 02-12-2015 |
20150351391 | PRESERVATIVE SYSTEM - Disclosed is a method of preserving a cosmetic or pharmaceutical formulation, the method comprising including a mixture of at least two of the following esters of salicylic acid and glycerin, or salts thereof, in the cosmetic or pharmaceutical formulation in an amount sufficient to reduce or inhibit growth of a microorganism in the cosmetic or pharmaceutical formulation: | 12-10-2015 |
20160159779 | CO-CRYSTAL OF THE PAR-1 RECEPTOR ANTAGONISTS VORAPAXAR AND ASPRIN - This invention relates to a co-crystal of vorapaxar and aspirin. The inventive co-crystal antagonizes the PAR-1 receptor. This invention also provides for pharmaceutical compositions comprising the inventive co-crystal as well as potentially to methods for the treatment, amelioration or prevention of conditions that could be treated by antagonizing the PAR-1 receptor. | 06-09-2016 |
20170231932 | METHODS OF USE FOR 2,5-DIHYDROXYBENZENE SULFONIC ACID COMPOUNDS FOR THE TREATMENT OF CANCER, ROSACEA AND PSORIASIS | 08-17-2017 |
20170233326 | IMPROVED COMPOSITIONS AND METHODS COMPRISING RESVERATROL | 08-17-2017 |